# Retraction Note: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis

**Authors:** Rui Han, Hongxing Yang, Lingeng Lu, Lizhu Lin

PMC · DOI: 10.1038/s41598-025-11770-9 · Scientific Reports · 2025-07-29

## Full-text entities

- **Genes:** CA12 (carbonic anhydrase 12) [NCBI Gene 771] {aka CA-XII, CAXII, HsT18816, T18816}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}
- **Diseases:** liver cancer (MESH:D006528)
- **Chemicals:** Tiliroside (MESH:C052083)
- **Cell lines:** Hep3B — Homo sapiens (Human), Childhood hepatocellular carcinoma, Cancer cell line (CVCL_0326)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12307769/full.md

---
Source: https://tomesphere.com/paper/PMC12307769